Insmed
INSM
413 hedge funds and large institutions have $13.7B invested in Insmed in 2024 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 186 increasing their positions, 113 reducing their positions, and 38 closing their positions.
97% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 38
65% more repeat investments, than reductions
Existing positions increased: 186 | Existing positions reduced: 113
17% more capital invested
Capital invested by funds: $11.7B → $13.7B (+$1.99B)
9% more funds holding
Funds holding: 378 → 413 (+35)
0.73% more ownership
Funds ownership: 108.7% → 109.43% (+0.73%)
0% more funds holding in top 10
Funds holding in top 10: 27 → 27 (0)
35% less call options, than puts
Call options by funds: $173M | Put options by funds: $268M
Top Buyers
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$513M |
| 2 |
State Street
Boston,
Massachusetts
|
+$112M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$83.4M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$68M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$65.6M |
Top Sellers
INSM Hedge Fund Activity: Q3 2024 in Review
413 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2024, worth a combined $13.7B — up 17% from $11.7B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new INSM positions and 38 closed out — a net gain of 37 holders — while 186 added to existing stakes and 113 trimmed.
The largest buyer was Darwin Global Management, adding an estimated $513M. The largest seller was Deep Track Capital, exiting entirely with an estimated $134M sold.
- 413 institutional investors held Insmed (INSM) as of Q3 2024, up from 378 in Q2 2024.
- Funds reported $13.7B of Insmed stock for Q3 2024, up 17% quarter-over-quarter.
- 75 funds opened new Insmed positions in Q3 2024 and 38 closed out, a net change of +37 holders.
- The largest Insmed buyer in Q3 2024 was Darwin Global Management, an estimated $513M added.
- The largest Insmed seller in Q3 2024 was Deep Track Capital, an estimated $134M sold.
Based on aggregated 13F filings for Q3 2024.